Key Points The Khorana score did risk-stratify cancer patients according to 6-month risk of VTE, but only for some cancer types. Absolute risk estimates were lower than previously reported, questioning… Click to show full abstract
Key Points The Khorana score did risk-stratify cancer patients according to 6-month risk of VTE, but only for some cancer types. Absolute risk estimates were lower than previously reported, questioning the benefit of ambulatory thromboprophylaxis in cancer patients.
               
Click one of the above tabs to view related content.